spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Medical Tourism Market to Hit US$ 605.2 Bn by 2035, Fueled by Cost Savings & Advanced Healthcare Services

Medical Tourism Market to reach US$ 605.2 Bn by 2035, growing at 20.1% CAGR, driven by cost savings and advanced healthcare access.

WILMINGTON, DE, UNITED STATES, August 15, 2025 /EINPresswire.com/ — The global medical tourism market, valued at US$ 77.8 Billion in 2024, is projected to grow at a CAGR of 20.1% from 2025 to 2035, reaching US$ 605.2 Billion by the end of 2035, according to Transparency Market Research. Rising healthcare costs in developed nations, combined with access to high-quality medical services at significantly lower prices in developing countries, are fueling robust industry growth.

The increasing elderly population, coupled with the growing number of uninsured individuals, is prompting patients to seek affordable yet sophisticated medical treatments abroad. From cosmetic surgeries with quick recovery times to advanced cardiovascular procedures, medical tourism is reshaping global healthcare access while supporting economic development in destination countries.

Medical tourism refers to patients traveling internationally for medical treatments ranging from complex procedures such as cardiac surgery, orthopedics, and neurosurgery to elective treatments like cosmetic surgery and dental care. Escalating healthcare expenses in developed economies and the availability of cost-effective, high-quality care in developing nations are major growth drivers.

In the United States alone, around 26 million people lacked health insurance and 68.5 million were without dental insurance in 2023. Over one million Americans travel abroad annually for medical services, where treatment costs can be 50% to 70% lower than in the U.S., even after factoring in travel expenses.

Hot this week

Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation

Daewoong Pharmaceutical said on October 17 that it met...

Novo Nordisk chair and independent directors to exit in strategy dispute

The chair of Wegovy maker Novo Nordisk and six...

Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG

Medical diagnostics firm Hologic has agreed to be acquired...

China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda

-China’s Innovent Biologics said on Wednesday it had signed...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img